Characterization of the raptor/4E-BP1 interaction by chemical cross-linking coupled with mass spectrometry analysis

Journal of Biological Chemistry

Volumn 289, Issue 8, 2014, Pages 4723-4734

  Coffman, Kimberly ^a   Yang, Bing ^b   Lu, Jie ^a   Tetlow, Ashley L ^a   Pelliccio, Emelia ^a   Lu, Shan ^b   Guo, Da Chuan ^c   Tang, Chun ^c   Dong, Meng Qiu ^b   Tamanoi, Fuyuhiko ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^c Wuhan National Laboratory for Optoelectronics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL CROSS-LINKING; INTRAMOLECULAR CROSS-LINKS; MASS SPECTROMETRY ANALYSIS; N-TERMINALS; PROTEIN-PROTEIN INTERACTIONS;

MASS SPECTROMETRY; PROTEINS;

CROSSLINKING;

BIS[SULFOSUCCINIMIDYL]SUBERATE; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; RAPTOR PROTEIN; REAGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL CROSS LINKING COUPLED WITH MASS SPECTROMETRY; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAPTOR CROSS LINKING REGION;

4E-BP1; CROSS-LINKING MASS SPECTROMETRY; MTOR; MTOR COMPLEX (MTORC); PROTEIN CROSS-LINKING; PROTEIN KINASES; RAPTOR; SIGNALING; TOS MOTIF;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CONSERVED SEQUENCE; CROSS-LINKING REAGENTS; HEK293 CELLS; HUMANS; LYSINE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; MUTATION; PEPTIDES; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; SUBSTRATE SPECIFICITY; TOR SERINE-THREONINE KINASES;

EID: 84896706986     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.482067     Document Type: Article

References (50)

1. Laplante, M., and Sabatini, D. M. (2009)mTORsignaling at a glance. J. Cell Sci. 122, 3589-3594
2. Polak, P., and Hall, M. N. (2009) mTOR and the control of whole body metabolism. Curr. Opin. Cell Biol. 21, 209-218
3. Wullschleger, S., Loewith, R., and Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484
4. Tamanoi, F., and Hall, M. N. (2010) Structure, Function and Regulation of TOR Complexes from Yeasts to Mammals Part B: The Enzymes, Vol. 28, Academic Press/Elsevier
5. Karbowniczek, M., Spittle, C. S., Morrison, T., Wu, H., and Henske, E. P. (2008) mTOR is activated in the majority of malignant melanomas. J. Invest. Dermatol. 128, 980-987
6. Robb, V. A., Karbowniczek, M., Klein-Szanto, A. J., and Henske, E. P. (2007) Activation of the mTOR signaling pathway in renal clear cell carcinoma. J. Urol. 177, 346-352
7. Molinolo, A. A., Hewitt, S. M., Amornphimoltham, P., Keelawat, S., Rangdaeng, S., Meneses García, A.,Raimondi, A. R., Jufe, R., Itoiz, M., Gao, Y., Saranath, D., Kaleebi, G. S., Yoo, G. H., Leak, L., Myers, E. M., Shintani, S., Wong, D., Massey, H. D., Yeudall, W. A., Lonardo, F., Ensley, J., and Gutkind, J. S. (2007) Dissecting the Akt/mammalian target of rapamycin signaling network. Emerging results from the head and neck cancer tissue array initiative. Clin. Cancer Res. 13, 4964-4973
8. Sato, T., Nakashima, A., Guo, L., Coffman, K., and Tamanoi, F. (2010) Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer. Oncogene 29, 2746-2752
9. Abraham, R. T. (2004) PI 3-kinase related kinases. "Big" players in stressinduced signaling pathways. DNA Repair 3, 883-887
10. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., and Hall, M. N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128
11. Sarbassov, D. D., Ali, S. M., Kim, D. H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D. M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and Raptorindependent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302
12. Gingras, A. C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., and Sonenberg, N. (1999) Regulation of 4E-BP1 phosphorylation. A novel two-step mechanism. Genes Dev. 13, 1422-1437
13. She, Q. B., Halilovic, E., Ye, Q., Zhen, W., Shirasawa, S., Sasazuki, T., Solit, D. B., and Rosen, N. (2010) 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell 18, 39-51
14. Hsieh, A. C., Costa, M., Zollo, O., Davis, C., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., and Ruggero, D. (2010) Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP1-eIF4E. Cancer Cell 17, 249-261
15. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D. M. (2002) mTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175
16. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., and Yonezawa, K. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189
17. Schalm, S. S., Fingar, D. C., Sabatini, D. M., and Blenis, J. (2003) TOS motif-mediated Raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13, 797-806
18. Eguchi, S., Tokunaga, C., Hidayat, S., Oshiro, N., Yoshino, K., Kikkawa, U., and Yonezawa, K. (2006) Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with Raptor and phosphorylation by mTOR in the regulation of cell size. Genes Cells 11, 757-766
19. Lee, V. H., Healy, T., Fonseca, B. D., Hayashi, A., and Proud, C. G. (2008) Analysis of the regulatory motifs in eukaryotic initiation factor 4E binding protein 1. FEBS J. 275, 2185-2199
20. Tabb, D. L. (2012) Evaluating protein interactions through cross-linking mass spectrometry. Nat. Methods 9, 879-881
21. Yang, B., Wu, Y. J., Zhu, M., Fan, S. B., Lin, J., Zhang, K., Li, S., Chi, H., Li, Y. X., Chen, H. F., Luo, S. K., Ding, Y. H., Wang, L. H., Hao, Z., Xiu, L. Y., Chen, S., Ye, K., He, S. M., and Dong, M. Q. (2012) Identification of crosslinked peptides from complex samples. Nat. Methods 9, 904-906
22. Sinz, A. (2003) Chemical cross-linking and mass spectrometry for mapping three-dimensional structures of proteins and protein complexes. J. Mass Spectrom. 38, 1225-1237
23. Leitner, A., Walzthoeni, T., Kahraman, A., Herzog, F., Rinner, O., Beck, M., and Aebersold, R. (2010) Probing native protein structures by chemical cross-linking, mass spectrometry, and bioinformatics. Mol. Cell. Proteomics 9, 1634-1649
24. Chen, Z. A., Jawhari, A., Fischer, L., Buchen, C., Tahir, S., Kamenski, T., Rasmussen, M., Lariviere, L., Bukowski-Wills, J. C., Nilges, M., Cramer, P., and Rappsilber, J. (2010) Architecture of the RNA polymerase II-TFIIF complex revealed by cross-linking and mass spectrometry. EMBO J. 29, 717-726
25. Rinner, O., Seebacher, J., Walzthoeni, T., Mueller, L. N., Beck, M., Schmidt, A., Mueller, M., and Aebersold, R. (2008) Identification of crosslinked peptides from large sequence databases. Nat. Methods 5, 315-318
26. Singh, P., Panchaud, A., and Goodlett, D. R. (2010) Chemical cross-linking and mass spectrometry as a low-resolution protein structure determination technique. Anal. Chem. 82, 2636-2642
27. Sato, T., Nakashima, A., Guo, L., and Tamanoi, F. (2009) Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J. Biol. Chem. 284, 12783-12791
28. Pandey, A., Andersen, J. S., and Mann, M. (2000) Use of mass spectrometry to study signaling pathways. Sci. STKE 2000, PL1
29. Roy, A., Kucukural, A., and Zhang, Y. (2010) I-TASSER. A unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725-738
30. Schwieters, C. D., Kuszewski, J. J., Tjandra, N., and Clore, G. M. (2003) The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160, 65-73
31. Bermejo, G. A., Clore, G. M., and Schwieters, C. D. (2012) Smooth statistical torsion angle potential derived from a large conformational database via adaptive kernel density estimation improves the quality of NMR protein structures. Protein Sci. 21, 1824-1836
32. Tang, C., and Clore, G. M. (2006) A simple and reliable approach to docking protein-protein complexes from very sparse NOE-derived intermolecular distance restraints. J. Biomol. NMR 36, 37-44
33. Pierce, B., and Weng, Z. (2007) ZRANK. Reranking protein docking predictions with an optimized energy function. Proteins 67, 1078-1086
34. DeLano, W. L. ( 2012) The PyMOL Molecular Graphics System, version 1.5.0.1, Schroedinger, LLC, New York
35. Moerke, N. J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M. Y., Fahmy, A., Gross, J. D., Degterev, A., Yuan, J., Chorev, M., Halperin, J. A., and Wagner, G. (2007) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128, 257-267
36. Yip, C. K., Murata, K., Walz, T., Sabatini, D. M., and Kang, S. A. (2010) Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol. Cell 38, 768-774
37. Tomoo, K., Matsushita, Y., Fujisaki, H., Abiko, F., Shen, X., Taniguchi, T., Miyagawa, H., Kitamura, K., Miura, K., and Ishida, T. (2005) Structural basis for mRNA cap-binding regulation of eukaryotic initiation factor 4E by 4E-binding protein, studied by spectroscopic, x-ray crystal structural, and molecular dynamics simulation methods. Biochim. Biophys. Acta 1753, 191-208
38. Rosettani, P., Knapp, S., Vismara, M. G., Rusconi, L., and Cameron, A. D. (2007) Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms. J. Mol. Biol. 368, 691-705
39. Brown, C. J., McNae, I., Fischer, P. M., and Walkinshaw, M. D. (2007) Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives. J. Mol. Biol. 372, 7-15
40. Liu W., Zhao R., McFarland C., Kieft, J., Niedzwiecka, A., Jankowska-Anyszka, M., Stepinski, J., Darzynkiewicz, E., Jones, D. N., and Davis, R. E. (2009) Structural insights into parasite eIF4E binding specificity for m7G and m2,2,7G mRNA caps. J. Biol. Chem. 284, 31336-31349
41. Liu, W., Jankowska-Anyszka, M., Piecyk, K., Dickson, L., Wallace, A., Niedzwiecka, A., Stepinski, J., Stolarski, R., Darzynkiewicz, E., Kieft, J., Zhao, R., Jones, D. N., and Davis, R. E. (2011) Structural basis for nematode eIF4E binding an m(2,2,7)G-Cap and its implications for translation initiation. Nucleic Acids Res. 39, 8820-8832
42. Siddiqui, N., Tempel, W., Nedyalkova, L., Volpon, L., Wernimont, A. K., Osborne, M. J., Park, H. W., and Borden, K. L. (2012) Structural insights into the allosteric effects of 4EBP1 on the eukaryotic translation initiation factor eIF4E. J. Mol. Biol. 415, 781-792
43. Fletcher, C. M., McGuire, A. M., Gingras, A. C., Li, H., Matsuo, H., Sonenberg, N., and Wagner, G. (1998) 4E binding proteins inhibit the translation factor eIF4E without folded structure. Biochemistry 37, 9-15
44. Poulin, F., Gingras, A. C., Olsen, H., Chevalier, S., and Sonenberg, N. (1998) 4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family. J. Biol. Chem. 273, 14002-14007
45. Gingras, A. C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., and Sonenberg, N. (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15, 2852-2864
46. Matsuo, H., Li, H., McGuire, A. M., Fletcher, C. M., Gingras, A. C., Sonenberg, N., and Wagner, G. (1997) Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein. Nat. Struct. Biol. 4, 717-724
47. Lazaris-Karatzas, A., Montine, K. S., and Sonenberg, N. (1990) Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5 cap. Nature 345, 544-547
48. Ruggero, D., and Pandolfi, P. P. (2003) Does the ribosome translate cancer? Nat. Rev. Cancer 3, 179-192
49. Rousseau, D., Gingras, A. C., Pause, A., and Sonenberg, N. (1996) The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 13, 2415-2420
50. Assouline, S., Culjkovic, B., Cocolakis, E., Rousseau, C., Beslu, N., Amri, A., Caplan, S., Leber, B., Roy, D. C., Miller, W. H., Jr., and Borden, K. L. (2009) Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML). A proof-of-principle clinical trial with ribavirin. Blood 114, 257-260